TIG Advisors »

Moonlake Immunot shares owned by TIG Advisors

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by TIG Advisors from 13F filings

Historical chart of TIG Advisors investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by TIG Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by TIG Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.4M 106k 60.39

More positions owned by TIG Advisors

United States Steel Corporation Put Option (X)
Capri Holdings SHS (CPRI)
stock
ImmunoGen
Ansys Call Option (ANSS)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Pioneer Natural Resources (PXD)
Albertsons Cos Common Stock Put Option (ACI)
Cleveland-cliffs (CLF)
Chevron Corporation (CVX)
Cytokinetics Com New Call Option (CYTK)
Argenx Se Sponsored Adr Call Option (ARGX)
Apellis Pharmaceuticals (APLS)
Gracell Biotechnologies Sponsored Ads
Neurocrine Biosciences Call Option (NBIX)

View all positions for TIG Advisors

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Federated Investors
Darwin Global Management
Holocene Advisors
Alliancebernstein
Fred Alger Management
Westfield Capital Management Company
Balyasny Asset Management
TimesSquare Capital Management
Caption Management
5AM Venture Management

View all funds holding Moonlake Immunot